Literature DB >> 24900875

Dual RXR Agonists and RAR Antagonists Based on the Stilbene Retinoid Scaffold.

Claudio Martínez1, Michele Lieb2, Susana Alvarez1, Fátima Rodríguez-Barrios1, Rosana Alvarez1, Harshal Khanwalkar2, Hinrich Gronemeyer2, Angel R de Lera1.   

Abstract

Arotinoids containing a C5,C8-diphenylnaphthalene-2-yl ring linked to a (C3-halogenated) benzoic acid via an ethenyl connector (but not the corresponding naphthamides), which are prepared by Horner-Wadsworth-Emmons reaction of naphthaldehydes and benzylphosphonates, display the rather unusual property of being RXR agonists (15-fold induction of the RXR reporter cell line was achieved at 3- to 10-fold lower concentration than 9-cis-retinoic acid) and RAR antagonists as shown by transient transactivation studies. The binding of such bulky ligands suggests that the RXR ligand-binding domain is endowed with some degree of structural elasticity.

Entities:  

Keywords:  Retinoid receptor subtypes; agonists; antagonists; arotinoids; molecular modeling; transactivation

Year:  2014        PMID: 24900875      PMCID: PMC4027779          DOI: 10.1021/ml400521f

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  42 in total

1.  Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARgamma.

Authors:  B P Klaholz; A Mitschler; M Belema; C Zusi; D Moras
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles.

Authors:  A Klapars; J C Antilla; X Huang; S L Buchwald
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

3.  Structural determinants of allosteric ligand activation in RXR heterodimers.

Authors:  Andrew I Shulman; Christopher Larson; David J Mangelsdorf; Rama Ranganathan
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

Review 4.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 5.  Design of selective nuclear receptor modulators: RAR and RXR as a case study.

Authors:  Angel R de Lera; William Bourguet; Lucia Altucci; Hinrich Gronemeyer
Journal:  Nat Rev Drug Discov       Date:  2007-10       Impact factor: 84.694

Review 6.  Copper-mediated coupling reactions and their applications in natural products and designed biomolecules synthesis.

Authors:  Gwilherm Evano; Nicolas Blanchard; Mathieu Toumi
Journal:  Chem Rev       Date:  2008-08       Impact factor: 60.622

7.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

Review 8.  The promise of retinoids to fight against cancer.

Authors:  L Altucci; H Gronemeyer
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

9.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

Authors:  J Y Chen; S Penco; J Ostrowski; P Balaguer; M Pons; J E Starrett; P Reczek; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  2 in total

Review 1.  A review of the molecular design and biological activities of RXR agonists.

Authors:  Nathalia Rodrigues de Almeida; Martin Conda-Sheridan
Journal:  Med Res Rev       Date:  2019-04-03       Impact factor: 12.944

2.  An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.

Authors:  Eswarkumar Nadendla; Catherine Teyssier; Vanessa Delfosse; Valérie Vivat; Gunasekaran Krishnasamy; Hinrich Gronemeyer; William Bourguet; Pierre Germain
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.